270 related articles for article (PubMed ID: 11376129)
1. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb.
O'Connor DP; Kay EW; Leader M; Murphy GM; Atkins GJ; Mabruk MJ
Mol Pathol; 2001 Jun; 54(3):165-9. PubMed ID: 11376129
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
[TBL] [Abstract][Full Text] [Related]
3. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity for Rb locus and pRb immunostaining in laryngeal cancer: a clinicopathologic, molecular and immunohistochemical study.
Pietruszewska W; Klatka J; Borzecki A; Rieske P
Folia Histochem Cytobiol; 2008; 46(4):479-85. PubMed ID: 19141402
[TBL] [Abstract][Full Text] [Related]
5. Frequent homozygous deletions of D13S218 on 13q14 in B-cell chronic lymphocytic leukemia independent of disease stage and retinoblastoma gene inactivation.
Newcomb EW; Thomas A; Selkirk A; Lee SY; Potmesil M
Cancer Res; 1995 May; 55(10):2044-7. PubMed ID: 7743499
[TBL] [Abstract][Full Text] [Related]
6. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
[TBL] [Abstract][Full Text] [Related]
8. [Loss of heterozygosity on chromosome 13 in squamous cell carcinomas of the larynx].
Bai S; Zhang X; Wang J
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):35-7. PubMed ID: 10743052
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
[TBL] [Abstract][Full Text] [Related]
10. TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with human papillomavirus status.
Cairey-Remonnay S; Humbey O; Mougin C; Algros MP; Mauny F; Kanitakis J; Euvrard S; Laurent R; Aubin F
J Invest Dermatol; 2002 Jun; 118(6):1026-31. PubMed ID: 12060398
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic analysis of the BRCA2 tumor suppressor gene region in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Jan; 35(1):1-9. PubMed ID: 18095987
[TBL] [Abstract][Full Text] [Related]
12. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma.
Yoo GH; Xu HJ; Brennan JA; Westra W; Hruban RH; Koch W; Benedict WF; Sidransky D
Cancer Res; 1994 Sep; 54(17):4603-6. PubMed ID: 8062250
[TBL] [Abstract][Full Text] [Related]
13. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3.
Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J
Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517
[TBL] [Abstract][Full Text] [Related]
14. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma.
Sakata K
J Oral Pathol Med; 1996 Jul; 25(6):302-7. PubMed ID: 8887073
[TBL] [Abstract][Full Text] [Related]
15. Molecular studies of loss of heterozygosity in Chinese sporadic retinoblastoma patients.
Zhang XL; Fu WL; Zhao HX; Zhou LX; Huang JF; Wang JH
Clin Chim Acta; 2005 Aug; 358(1-2):75-80. PubMed ID: 15921673
[TBL] [Abstract][Full Text] [Related]
16. Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma.
Shattuck TM; Kim TS; Costa J; Yandell DW; Imanishi Y; Palanisamy N; Gaz RD; Shoback D; Clark OH; Monchik JM; Wierman ME; Hollenberg A; Tojo K; Chaganti RS; Arnold A
Clin Endocrinol (Oxf); 2003 Aug; 59(2):180-9. PubMed ID: 12864795
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
Pearce SH; Trump D; Wooding C; Sheppard MN; Clayton RN; Thakker RV
Clin Endocrinol (Oxf); 1996 Aug; 45(2):195-200. PubMed ID: 8881452
[TBL] [Abstract][Full Text] [Related]
18. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R
Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692
[TBL] [Abstract][Full Text] [Related]
20. Genetic changes during the multistage pathogenesis of human papillomavirus positive and negative vulvar carcinomas.
Flowers LC; Wistuba II; Scurry J; Muller CY; Ashfaq R; Miller DS; Minna JD; Gazdar AF
J Soc Gynecol Investig; 1999; 6(4):213-21. PubMed ID: 10486784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
